The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug (Q37975816)
Jump to navigation
Jump to search
scientific article published on 05 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug |
scientific article published on 05 January 2012 |
Statements
1 reference
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug (English)
1 reference
1 reference
Jeffery W Kelly
1 reference
Steven M Johnson
1 reference
Stephen Connelly
1 reference
Colleen Fearns
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference